Search Results - American Academy of Neurology

Nusinersen in patients older than 7 months with spinal muscular atrophy type 1 by Aragon-Gawinska, Karolina, Seferian, Andreea, Daron, Aurore, Gargaun, Elena, Vuillerot, Carole, Cances, Claude, Ropars, Juliette, Chouchane, Mondher, Cuppen, Inge, Hughes, Imelda, Illingworth, Marjorie, Marini-Bettolo, Chiara, Rambaud, Jerome, Taytard, Jessica, Annoussamy, Melanie, Scoto, Mariacristina, Gidaro, Teresa, Servais, Laurent

“…Objective To evaluate the safety and clinical efficacy of nusinersen in patients older than 7 months with spinal muscular atrophy type 1 (SMA1). Methods…”
Get full text

Evaluation of efficacy and tolerability of first-line therapies in NMOSD by Poupart, Julien, Giovannelli, Jonathan, Deschamps, Romain, Audoin, Bertrand, Ciron, Jonathan, Maillart, Elisabeth, Papeix, Caroline, Collongues, Nicolas, Bourre, Bertrand, Cohen, Mickael, Wiertlewski, Sandrine, Outteryck, Olivier, Laplaud, David, Vukusic, Sandra, Marignier, Romain, Zephir, Hélène

“…OBJECTIVETo compare the efficacy and the risk of severe infectious events of immunosuppressive agents used early as first-line therapy in patients with…”
Get full text

Population-based analysis of survival in spinal muscular atrophy by Wijngaarde, Camiel A., Stam, Marloes, Otto, Louise A.M., van Eijk, Ruben P.A., Cuppen, Inge, Veldhoen, Esther S., van den Berg, Leonard H., Wadman, Renske I., van der Pol, W. Ludo

“…OBJECTIVETo investigate probabilities of survival and its surrogate, that is, mechanical ventilation, in patients with spinal muscular atrophy (SMA). METHODSWe…”
Get full text

Cancer Incidence and Mortality Rates in Multiple Sclerosis: A Matched Cohort Study by Marrie, Ruth Ann, Maxwell, Colleen, Mahar, Alyson, Ekuma, Okechukwu, McClintock, Chad, Seitz, Dallas, Webber, Colleen, Groome, Patti A.

“…To determine whether cancer risk differs in people with and without multiple sclerosis (MS), we compared incidence rates and cancer-specific mortality rates in…”
Get full text

Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting by Bis, Joshua C, Smith, Albert Vernon, Saba, Yasaman, Luciano, Michelle, Bastin, Mark E, Lemmens, Robin, Ames, David, Chong, Elizabeth, van der Lugt, Aad, Jimenez-Conde, Jordi, Rundek, Tatjana, Arnett, Donna K, Jern, Christina, Johnson, Julie A, Benavente, Oscar R, Geerlings, Mirjam I, Tzourio, Christophe, Sachdev, Perminder S, Markus, Hugh S, Seshadri, Sudha, Anderson, Christopher D, de Bakker, Paul IW, Engström, Gunnar, Kissela, Brett M, Pera, Joanna, Soriano-Tárraga, Carolina, Stanne, Tara, Nyquist, Paul, Drazyk, Anna, Markus, Hugh, Chasman, Daniel, Elkind, Mitchell, Bijlenga, Philippe, Yue, Suo, Mateen, Farrah, Meschia, James, Pare, Guillaume, Klijn, Karin, Kamatani, Yoichiro, Tregouet, David, Carrera, Caty, Ruigrok, Ynte, Sargurupremraj, Murali, Liebeskind, David, Tan, Rhea, Broderick, Joseph, Sale, Michele, Konrad, Jan, Nordestgaard, Børge G, Psaty, Bruce M, Benn, Marianne, Farrall, Martin, Nalls, Mike, Oliveira, Sofia A, Becker, James T, Carlsson, Cynthia M, Carney, Regina M, Crocco, Elizabeth A, Faber, Kelley M, Farlow, Martin R, Farrer, Lindsay A, Gearing, Marla, Gilbert, John R, Hamilton-Nelson, Kara L, Haroutunian, Vahram, Huebinger, Ryan M, Kukull, Walter A, Lah, James J, Li, Ge, Lunetta, Kathryn L, Mack, Wendy J, Manly, Jennifer J, Masliah, Eliezer, Miller, Carol A, Pierce, Aimee, Potter, Huntington, Raj, Ashok, Sano, Mary, Spina, Salvatore, Tanzi, Rudolph E, Vinters, Harry V, Yu, Chang-En, Yu, Lei, Liu, Yongmei, Johnson, Andrew D, deStefano, Anita L, van Buchem, Mark A, Boerwinkle, Eric, de Craen, Anton J.M, Ibrahim-Verbaas, Carla A, Oostra, Ben A, Cupples, L Adrienne, Meisinger, Christa, Nambi, Vijay, Halperin, Eran, Orru, Marco, Ernst, Florian, Chilukoti, Ravi Kumar, Wilson, James F, Gudnason, Vilmundur

“…OBJECTIVETo explore genetic and lifestyle risk factors of MRI-defined brain infarcts (BI) in large population-based cohorts. METHODSWe performed meta-analyses…”
Get full text

First-ever ischemic stroke and increased risk of incident heart disease in older adults by Sposato, Luciano A., Lam, Melody, Allen, Britney, Richard, Lucie, Shariff, Salimah Z., Saposnik, Gustavo

“…OBJECTIVEPoststroke cardiac complications are common. It is unknown whether the reason is shared risk factors and preexisting heart disease or…”
Get full text

Antiepileptic drugs are not independently associated with cognitive dysfunction by Foster, Emma, Malpas, Charles B., Ye, Karena, Johnstone, Benjamin, Carney, Patrick W., Velakoulis, Dennis, O'Brien, Terence J., Kwan, Patrick

“…OBJECTIVETo test the hypothesis that individual antiepileptic drugs (AEDs) are not associated with cognitive impairment beyond other clinically relevant…”
Get full text

Headache and impaired consciousness level associated with SARS-CoV-2 in CSF: A case report by Cebrián, José, Gonzalez-Martinez, Alicia, García-Blanco, María J., Celdrán-Vivancos, Diego, Palacios, Eduardo López, Reig-Roselló, Gemma, Casado-Fernández, Laura, Vivancos, José, Gago-Veiga, Ana Beatriz

Get full text

Cancer Risk Among Patients With Multiple Sclerosis by Pierret, Chloe, Mulliez, Aurelien, Le Bihan-Benjamin, Christine, Moisset, Xavier, Bousquet, Philippe-Jean, Leray, Emmanuelle

“…Background and objectives: Previous literature has been diverging on cancer risk in people with multiple sclerosis (PwMS). Therefore, this study compared the…”
Get full text

Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease by Hümmert, Martin W, Schöppe, Louisa M, Bellmann-Strobl, Judith, Siebert, Nadja, Paul, Friedemann, Duchow, Ankelien, Pellkofer, Hannah, Kümpfel, Tania, Havla, Joachim, Jarius, Sven, Wildemann, Brigitte, Berthele, Achim, Bergh, Florian Then, Pawlitzki, Marc, Klotz, Luisa, Kleiter, Ingo, Stangel, Martin, Gingele, Stefan, Weber, Martin S, Faiss, Juergen H, Pul, Refik, Walter, Annette, Zettl, Uwe K, Senel, Makbule, Stellmann, Jan-Patrick, Häußler, Vivien, Hellwig, Kerstin, Ayzenberg, Ilya, Aktas, Orhan, Ringelstein, Marius, Schreiber-Katz, Olivia, Trebst, Corinna

“…Background and Objectives To evaluate costs and health-related quality of life (HRQoL) of neuromyelitis optica spectrum disorders (NMOSD) and myelin…”
Get full text

Oral anticoagulation in patients with chronic kidney disease: A systematic review and meta-analysis by Malhotra, Konark, Ishfaq, Muhammad F, Goyal, Nitin, Katsanos, Aristeidis H, Parissis, John, Alexandrov, Anne W, Alexandrov, Andrei V, Tsivgoulis, Georgios

“…OBJECTIVEData regarding the efficacy and safety of warfarin and non-vitamin K antagonist oral anticoagulant (NOAC) among patients with chronic kidney disease…”
Get full text

Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis by Hay, Marion, Rollot, Fabien, Casey, Romain, Kerbrat, Anne, Edan, Gilles, Mathey, Guillaume, Labauge, Pierre, de Sèze, Jérôme, Vukusic, Sandra, Laplaud, David-Axel, Papeix, Caroline, Moreau, Thibault, Thouvenot, Eric, Defer, Gilles, Lebrun-Frénay, Christine, Ciron, Jonathan, Berger, Eric, Stankoff, Bruno, Clavelou, Pierre, Maillart, Elisabeth, Heinzlef, Olivier, Zéphir, Hélène, Ruet, Aurélie, Casez, Olivier, Moulin, Solène, Al-Khedr, Abdullatif, Bourre, Bertrand, Pelletier, Jean, Magy, Laurent, Neau, Jean-Philippe, Camdessanché, Jean-Philippe, Doghri, Inès, Wahab, Abir, Tchikviladzé, Maia, Labeyrie, Céline, Hankiewicz, Karolina, Le Page, Emmanuelle, Michel, Laure

“…Background and objectives: Although rituximab failed to demonstrate a significant effect on disability progression in primary progressive multiple sclerosis…”
Get full text

Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk by Lennon, Matthew, Lipnicki, Darren, Lam, Ben Chun Pan, Crawford, John, Schutte, Aletta, Peters, Ruth, Rydberg-Sterner, Therese, Najar, Jenna, Skoog, Ingmar, Riedel-Heller, Steffi, Röhr, Susanne, Pabst, Alexander, Lobo, Antonio, De-La-Cámara, Concepción, Lobo, Elena, Lipton, Richard, Katz, Mindy, Derby, Carol, Kim, Ki Woong, Han, Ji Won, Oh, Dae Jong, Rolandi, Elena, Davin, Annalisa, Rossi, Michele, Scarmeas, Nikolaos, Yannakoulia, Mary, Dardiotis, Themis, Hendrie, Hugh, Gao, Sujuan, Carriere, Isabelle, Ritchie, Karen, Anstey, Kaarin, Cherbuin, Nicolas, Xiao, Shifu, Yue, Ling, Li, Wei, Guerchet, Maëlenn, Preux, Pierre-Marie, Aboyans, Victor, Haan, Mary, Aiello, Allison, Scazufca, Marcia, Sachdev, Perminder

“…Background and objectives: Previous randomized controlled trials and longitudinal studies have indicated that ongoing antihypertensive use in late life reduces…”
Get full text

Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France by Moisset, Xavier, Leray, Emmanuelle, Chenaf, Chouki, Taithe, Frederic, Vukusic, Sandra, Mulliez, Aurélien, Clavelou, Pierre

“…Background and objectives: People with multiple sclerosis (MS) have an increased risk of severe coronavirus infection due to their level of motor disability or…”
Get full text

The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test by Villain, Nicolas, Paretsky, Melissa S

“…The study by Bieger highlights the implications of differences between AD diagnostic guidelines. The findings confirming a benign prognosis in cognitively…”
Get full text

Sodium channel Nav1.8: Emerging links to human disease by Han, Chongyang, Huang, Jianying, Waxman, Stephen G

“…The NaV1.8 sodium channel, encoded by gene SCN10A, was initially termed sensory neuron–specific (SNS) due to prominent expression in primary sensory neurons…”
Get full text

Reader Response: Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study by Khouri, Charles, Pariente, Antoine

Get full text

Teaching Neuroanatomy in the 19th Century: Dr Auzoux’s Papier-mâché Anatomical Models (S12.003) by Auffret, Manon

“…Abstract only…”
Get full text

Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease by Hopfner, Franziska, Wod, Mette, Höglinger, Günter U, Blaabjerg, Morten, Rösler, Thomas W, Kuhlenbäumer, Gregor, Christensen, Kaare, Deuschl, Günther, Pottegård, Anton

“…OBJECTIVETo verify the previously reported association between long-term use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk…”
Get full text

Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry by Romero-Sánchez, Carlos Manuel, Díaz-Maroto, Inmaculada, Fernández-Díaz, Eva, Sánchez-Larsen, Álvaro, Layos-Romero, Almudena, García-García, Jorge, González, Esther, Redondo-Peñas, Inmaculada, Perona-Moratalla, Ana Belén, Del Valle-Pérez, José Antonio, Gracia-Gil, Julia, Rojas-Bartolomé, Laura, Feria-Vilar, Inmaculada, Monteagudo, María, Palao, María, Palazón-García, Elena, Alcahut-Rodríguez, Cristian, Sopelana-Garay, David, Moreno, Yóscar, Ahmad, Javaad, Segura, Tomás

“…OBJECTIVEThe coronavirus disease 2019 (COVID-19) has spread worldwide since December 2019. Neurologic symptoms have been reported as part of the clinical…”
Get full text